Last reviewed · How we verify

NCT06141759

The Effect of Conservative Treatment on Perceptual and Cognitive Asymmetry in Scoliosis

Completed NA Last updated 21 November 2023
What this trial tests

NA trial testing Exercise in Adolescent Idiopathic Scoliosis in 30 participants. Completed in 10 July 2023.

Timeline
1 January 2023
Primary endpoint
1 July 2023
10 July 2023

Quick facts

Lead sponsorBandırma Onyedi Eylül University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date1 January 2023
Primary completion1 July 2023
Estimated completion10 July 2023
Sites2 locations across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bandırma Onyedi Eylül University

Who can join

Adults 10 to 16, any sex, with Adolescent Idiopathic Scoliosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adolescent idiopathic scoliosis (AIS) patients have been found to exhibit cortical asymmetry. This study aimed to examine the impact of conservative treatments on perceptual and cognitive asymmetry in the auditory system assessed by dichotic listening in AIS patients with thoracic major curves.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effect of Schroth Best Practice exercises and Cheneau brace treatment on perceptual and cognitive asymmetry in adolescent idiopathic scoliosis with thoracic major curve.
    Akçay B, İnanç G. · · 2024 · cited 2× · PMID 38123885 · DOI 10.1007/s11845-023-03593-2

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Adolescent Idiopathic Scoliosis

Currently open trials in the same condition.

Other Bandırma Onyedi Eylül University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06141759.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing